Where I see patients (1)
Selected research
-
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, Plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers.
Cancer research communications
-
Creation of a sustainable longitudinal women in Leadership Development (WILD) curriculum focused on graduate medical education trainees.
BMC medical education
-
A robust ensemble feature selection approach to prioritize genes associated with survival outcome in high-dimensional gene expression data.
Frontiers in systems biology
Clinical trials
A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin...
To evaluate the safety of ATG-101. It is the responsibility of the investigator to record and document all AEs (occurring from the first dose of study treatment on C1D1) throughout the study. Clinically significant symptoms and si...
Recruiting